Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Initiation and Maintenance Disorders | 19 | 2025 | 102 | 4.730 |
Why?
|
| Sleep Wake Disorders | 9 | 2025 | 187 | 2.460 |
Why?
|
| Sleep | 16 | 2024 | 369 | 2.060 |
Why?
|
| Menopause | 7 | 2025 | 90 | 1.570 |
Why?
|
| Pregnancy Complications | 4 | 2022 | 549 | 1.050 |
Why?
|
| Women's Health | 4 | 2019 | 150 | 0.840 |
Why?
|
| Restless Legs Syndrome | 1 | 2022 | 16 | 0.770 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2023 | 232 | 0.750 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2022 | 75 | 0.720 |
Why?
|
| Mood Disorders | 1 | 2019 | 128 | 0.590 |
Why?
|
| Premature Birth | 1 | 2022 | 417 | 0.560 |
Why?
|
| Pain | 1 | 2020 | 482 | 0.550 |
Why?
|
| Postpartum Period | 1 | 2019 | 229 | 0.550 |
Why?
|
| Actigraphy | 3 | 2024 | 47 | 0.530 |
Why?
|
| Menstrual Cycle | 3 | 2024 | 37 | 0.530 |
Why?
|
| von Willebrand Factor | 1 | 2018 | 202 | 0.520 |
Why?
|
| Interleukin-6 | 1 | 2018 | 449 | 0.500 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 934 | 0.430 |
Why?
|
| Melatonin | 4 | 2013 | 30 | 0.350 |
Why?
|
| Inflammation | 1 | 2018 | 1591 | 0.330 |
Why?
|
| Circadian Rhythm | 5 | 2019 | 297 | 0.310 |
Why?
|
| Sleep Medicine Specialty | 2 | 2020 | 7 | 0.300 |
Why?
|
| Affect | 3 | 2025 | 172 | 0.300 |
Why?
|
| Emotions | 2 | 2024 | 364 | 0.270 |
Why?
|
| Polysomnography | 5 | 2024 | 153 | 0.270 |
Why?
|
| Female | 26 | 2025 | 71537 | 0.270 |
Why?
|
| Depression | 5 | 2025 | 1355 | 0.270 |
Why?
|
| Postmenopause | 2 | 2017 | 155 | 0.240 |
Why?
|
| Adult | 16 | 2025 | 31830 | 0.220 |
Why?
|
| Humans | 33 | 2025 | 133547 | 0.220 |
Why?
|
| Natural Language Processing | 1 | 2024 | 68 | 0.210 |
Why?
|
| Sleep Apnea, Central | 1 | 2023 | 10 | 0.200 |
Why?
|
| Depressive Disorder | 3 | 2012 | 485 | 0.200 |
Why?
|
| Stroke Rehabilitation | 1 | 2023 | 70 | 0.190 |
Why?
|
| Stress, Psychological | 2 | 2025 | 601 | 0.190 |
Why?
|
| Middle Aged | 16 | 2024 | 29254 | 0.190 |
Why?
|
| Menstruation | 1 | 2021 | 30 | 0.180 |
Why?
|
| Self-Management | 1 | 2023 | 103 | 0.180 |
Why?
|
| Body Mass Index | 4 | 2018 | 1713 | 0.170 |
Why?
|
| Cognition | 3 | 2021 | 814 | 0.170 |
Why?
|
| Social Media | 1 | 2022 | 121 | 0.170 |
Why?
|
| Machine Learning | 1 | 2024 | 334 | 0.170 |
Why?
|
| Dreams | 1 | 2020 | 23 | 0.170 |
Why?
|
| Pregnancy | 4 | 2022 | 7528 | 0.160 |
Why?
|
| Advisory Committees | 1 | 2020 | 158 | 0.160 |
Why?
|
| Progesterone | 3 | 2012 | 634 | 0.160 |
Why?
|
| Pregnancy Outcome | 1 | 2022 | 625 | 0.150 |
Why?
|
| Cesarean Section | 1 | 2022 | 400 | 0.150 |
Why?
|
| Behavior Therapy | 1 | 2021 | 268 | 0.150 |
Why?
|
| Ovariectomy | 1 | 2019 | 188 | 0.150 |
Why?
|
| Berlin | 1 | 2018 | 3 | 0.150 |
Why?
|
| Hot Flashes | 1 | 2018 | 7 | 0.150 |
Why?
|
| Orgasm | 1 | 2017 | 7 | 0.140 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 637 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2025 | 870 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2024 | 792 | 0.130 |
Why?
|
| Behavioral Medicine | 1 | 2016 | 11 | 0.130 |
Why?
|
| Geographic Mapping | 1 | 2016 | 15 | 0.130 |
Why?
|
| Pandemics | 2 | 2022 | 1190 | 0.130 |
Why?
|
| Dementia | 1 | 2021 | 488 | 0.130 |
Why?
|
| Pilot Projects | 1 | 2020 | 1484 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2020 | 776 | 0.120 |
Why?
|
| Medically Underserved Area | 1 | 2016 | 94 | 0.120 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 471 | 0.120 |
Why?
|
| Sexual Behavior | 1 | 2017 | 250 | 0.120 |
Why?
|
| Intimate Partner Violence | 1 | 2015 | 28 | 0.120 |
Why?
|
| Young Adult | 7 | 2025 | 9869 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2018 | 604 | 0.110 |
Why?
|
| Stroke | 1 | 2023 | 1073 | 0.110 |
Why?
|
| Affective Symptoms | 1 | 2015 | 63 | 0.110 |
Why?
|
| Phenotype | 1 | 2024 | 4551 | 0.110 |
Why?
|
| Surveys and Questionnaires | 4 | 2018 | 3977 | 0.100 |
Why?
|
| Insulin Resistance | 1 | 2018 | 696 | 0.100 |
Why?
|
| Hydrocortisone | 1 | 2013 | 246 | 0.100 |
Why?
|
| Blood Pressure | 1 | 2018 | 1420 | 0.100 |
Why?
|
| Mental Health | 1 | 2015 | 370 | 0.090 |
Why?
|
| Estradiol | 2 | 2012 | 558 | 0.090 |
Why?
|
| Seasons | 1 | 2013 | 330 | 0.090 |
Why?
|
| Veterans | 1 | 2023 | 1768 | 0.090 |
Why?
|
| Aged | 7 | 2024 | 21637 | 0.090 |
Why?
|
| Neoplasms | 2 | 2024 | 3028 | 0.080 |
Why?
|
| Heart Failure | 1 | 2023 | 2423 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8588 | 0.080 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2009 | 51 | 0.080 |
Why?
|
| Biomarkers | 1 | 2018 | 3429 | 0.070 |
Why?
|
| Comorbidity | 2 | 2024 | 1620 | 0.070 |
Why?
|
| Male | 11 | 2025 | 65791 | 0.070 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2007 | 198 | 0.070 |
Why?
|
| Estrogens | 1 | 2009 | 523 | 0.060 |
Why?
|
| Adolescent | 5 | 2025 | 20516 | 0.060 |
Why?
|
| Sexual Partners | 2 | 2017 | 87 | 0.060 |
Why?
|
| Unsupervised Machine Learning | 1 | 2024 | 14 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2012 | 850 | 0.050 |
Why?
|
| Benzhydryl Compounds | 1 | 2004 | 68 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 987 | 0.050 |
Why?
|
| Logistic Models | 2 | 2019 | 1907 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2007 | 579 | 0.050 |
Why?
|
| Hemiplegia | 1 | 2023 | 46 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2024 | 439 | 0.050 |
Why?
|
| Quality of Life | 2 | 2024 | 2147 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2004 | 167 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 173 | 0.040 |
Why?
|
| Fatigue | 1 | 2021 | 203 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1495 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2023 | 17401 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 377 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2013 | 3088 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2024 | 5190 | 0.040 |
Why?
|
| Goals | 1 | 2020 | 133 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2012 | 1045 | 0.040 |
Why?
|
| Medicare | 1 | 2023 | 463 | 0.040 |
Why?
|
| Survivors | 1 | 2021 | 359 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2021 | 12997 | 0.030 |
Why?
|
| Age Factors | 1 | 2024 | 2987 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 3736 | 0.030 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2017 | 89 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 1 | 2019 | 214 | 0.030 |
Why?
|
| Cities | 1 | 2016 | 51 | 0.030 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2017 | 80 | 0.030 |
Why?
|
| Health Personnel | 1 | 2020 | 540 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 1189 | 0.030 |
Why?
|
| United States | 2 | 2023 | 11683 | 0.030 |
Why?
|
| Darkness | 1 | 2013 | 27 | 0.030 |
Why?
|
| Periodicity | 1 | 2013 | 55 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 1782 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1334 | 0.030 |
Why?
|
| Light | 1 | 2013 | 183 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 333 | 0.020 |
Why?
|
| Time Factors | 2 | 2013 | 6581 | 0.020 |
Why?
|
| California | 1 | 2012 | 143 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 261 | 0.020 |
Why?
|
| Child | 2 | 2021 | 25761 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 722 | 0.020 |
Why?
|
| Suicidal Ideation | 1 | 2011 | 251 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2011 | 478 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 482 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2007 | 142 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 6577 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 91 | 0.020 |
Why?
|
| Reaction Time | 1 | 2007 | 181 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 183 | 0.020 |
Why?
|
| Perception | 1 | 2007 | 236 | 0.020 |
Why?
|
| Memory | 1 | 2007 | 358 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 5466 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 3704 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 11101 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 7181 | 0.010 |
Why?
|